Arcturus Therapeutics is developing a portfolio of nucleic acid therapeutics for treatment of diseases with high unmet medical needs. Our hope and vision is to build transformative, life-changing medicines for patients and their families.
Our team has extensive experience in the discovery and development of RNA medicines, as well as design and utilization of lipid-mediated drug delivery systems. This combination of in-house expertise, innovative spirit, and passion for what we do, uniquely positions us to catalyze the next generation of nucleic medicines.
December 3, 2018
Arcturus Therapeutics to Host a Key Opinion Leader Call on Ornithine Transcarbamylase (OTC) Deficiency on December 11
November 7, 2018
Arcturus Therapeutics Provides Corporate Update and Reports Third Quarter 2018 Financial Results
November 5, 2018
Arcturus Therapeutics Hosts Ribbon Cutting Ceremony for its Research and Development Facility